Literature DB >> 26377947

Premenstrual Dysphoric Disorder: Epidemiology and Treatment.

Liisa Hantsoo1, C Neill Epperson2.   

Abstract

Recently designated as a disorder in the DSM-5, premenstrual dysphoric disorder (PMDD) presents an array of avenues for further research. PMDD's profile, characterized by cognitive-affective symptoms during the premenstruum, is unique from that of other affective disorders in its symptoms and cyclicity. Neurosteroids may be a key contributor to PMDD's clinical presentation and etiology, and represent a potential avenue for drug development. This review will present recent literature on potential contributors to PMDD's pathophysiology, including neurosteroids and stress, and explore potential treatment targets.

Entities:  

Keywords:  GABA; Menstrual cycle; PMDD; PMS; Premenstrual

Mesh：

Substances：

Year:  2015        PMID： 26377947      PMCID： PMC4890701          DOI： 10.1007/s11920-015-0628-3

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN： 1523-3812            Impact factor:   5.285


  107 in total

1.  Toward a functional neuroanatomy of premenstrual dysphoric disorder.

Authors:  Xenia Protopopescu; Oliver Tuescher; Hong Pan; Jane Epstein; James Root; Luke Chang; Margaret Altemus; Margaret Polanecsky; Bruce McEwen; Emily Stern; David Silbersweig
Journal:  J Affect Disord       Date:  2007-11-26       Impact factor: 4.839

2.  Psychological intervention for premenstrual syndrome: a meta-analysis of randomized controlled trials.

Authors:  Jason W Busse; Victor M Montori; Catherine Krasnik; Irene Patelis-Siotis; Gordon H Guyatt
Journal:  Psychother Psychosom       Date:  2008-10-14       Impact factor: 17.659

Review 3.  A model to explain the therapeutic effects of serotonin reuptake inhibitors: the role of 5-HT2 receptors.

Authors:  Mikael Landén; Michael E Thase
Journal:  Psychopharmacol Bull       Date:  2006

4.  Complex estrogenic regulation of catechol-O-methyltransferase (COMT) in rats.

Authors:  N Schendzielorz; A Rysa; I Reenila; A Raasmaja; P T Mannisto
Journal:  J Physiol Pharmacol       Date:  2011-08       Impact factor: 3.011

Review 5.  Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons.

Authors:  T Bäckström; D Haage; M Löfgren; I M Johansson; J Strömberg; S Nyberg; L Andréen; L Ossewaarde; G A van Wingen; S Turkmen; S K Bengtsson
Journal:  Neuroscience       Date:  2011-05-13       Impact factor: 3.590

6.  Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes.

Authors:  L D Griffin; S H Mellon
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

7.  Placebo-controlled trial comparing intermittent and continuous paroxetine in premenstrual dysphoric disorder.

Authors:  Mikael Landén; Hans Nissbrandt; Christer Allgulander; Karin Sörvik; Christina Ysander; Elias Eriksson
Journal:  Neuropsychopharmacology       Date:  2006-10-11       Impact factor: 7.853

8.  ACTH and cortisol response to Dex/CRH testing in women with and without premenstrual dysphoria during GnRH agonist-induced hypogonadism and ovarian steroid replacement.

Authors:  Ellen E Lee; Lynnette K Nieman; Pedro E Martinez; Veronica L Harsh; David R Rubinow; Peter J Schmidt
Journal:  J Clin Endocrinol Metab       Date:  2012-03-30       Impact factor: 5.958

9.  Brain-derived neurotrophic factor plasma variation during the different phases of the menstrual cycle in women with premenstrual syndrome.

Authors:  Alessandra Cubeddu; Fiorella Bucci; Andrea Giannini; Marinella Russo; Diana Daino; Natalia Russo; Sara Merlini; Nicola Pluchino; Valeria Valentino; Elena Casarosa; Stefano Luisi; Andrea Riccardo Genazzani
Journal:  Psychoneuroendocrinology       Date:  2010-10-08       Impact factor: 4.905

10.  Allopregnanolone serum concentrations and diurnal cortisol secretion in women with premenstrual dysphoric disorder.

Authors:  Birgitta Segebladh; Elin Bannbers; Lena Moby; Sigrid Nyberg; Marie Bixo; Torbjörn Bäckström; Inger Sundström Poromaa
Journal:  Arch Womens Ment Health       Date:  2013-01-18       Impact factor: 3.633
View more
  45 in total

Review 1.  Depression During and After the Perimenopause: Impact of Hormones, Genetics, and Environmental Determinants of Disease.

Authors:  Joyce T Bromberger; Cynthia Neill Epperson
Journal:  Obstet Gynecol Clin North Am       Date:  2018-10-25       Impact factor: 2.844

2.  Making Strides to Simplify Diagnosis of Premenstrual Dysphoric Disorder.

Authors:  C Neill Epperson; Liisa V Hantsoo
Journal:  Am J Psychiatry       Date:  2017-01-01       Impact factor: 18.112

3.  A novel therapeutic approach for treatment of catamenial epilepsy.

Authors:  Suchitra Joshi; Huayu Sun; Karthik Rajasekaran; John Williamson; Edward Perez-Reyes; Jaideep Kapur
Journal:  Neurobiol Dis       Date:  2017-12-21       Impact factor: 5.996

Review 4.  Sex as a Biological Variable: Who, What, When, Why, and How.

Authors:  Tracy L Bale; C Neill Epperson
Journal:  Neuropsychopharmacology       Date:  2016-09-23       Impact factor: 7.853

Review 5.  Hormonal Treatments for Major Depressive Disorder: State of the Art.

Authors:  Jennifer B Dwyer; Awais Aftab; Rajiv Radhakrishnan; Alik Widge; Carolyn I Rodriguez; Linda L Carpenter; Charles B Nemeroff; William M McDonald; Ned H Kalin
Journal:  Am J Psychiatry       Date:  2020-05-27       Impact factor: 18.112

6.  Fluctuations in progesterone moderate the relationship between daily mood and alcohol use in young adult women.

Authors:  Cathryn Glanton Holzhauer; Stephanie E Wemm; Edelgard Wulfert; Zhimin Tim Cao
Journal:  Addict Behav       Date:  2019-10-15       Impact factor: 3.913

Review 7.  Progesterone, reproduction, and psychiatric illness.

Authors:  Lindsay R Standeven; Katherine O McEvoy; Lauren M Osborne
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2020-06-18       Impact factor: 5.237

8.  IgA/IgM responses to tryptophan and tryptophan catabolites (TRYCATs) are differently associated with prenatal depression, physio-somatic symptoms at the end of term and premenstrual syndrome.

Authors:  Chutima Roomruangwong; Buranee Kanchanatawan; Sunee Sirivichayakul; George Anderson; André F Carvalho; Sebastien Duleu; Michel Geffard; Michael Maes
Journal:  Mol Neurobiol       Date:  2016-04-01       Impact factor: 5.590

Review 9.  What Does Sex Have to Do with It? The Role of Sex as a Biological Variable in the Development of Posttraumatic Stress Disorder.

Authors:  Sara L Kornfield; Liisa Hantsoo; C Neill Epperson
Journal:  Curr Psychiatry Rep       Date:  2018-05-18       Impact factor: 5.285

Review 10.  Suicide Risk and the Menstrual Cycle: a Review of Candidate RDoC Mechanisms.

Authors:  Sarah A Owens; Tory Eisenlohr-Moul
Journal:  Curr Psychiatry Rep       Date:  2018-10-06       Impact factor: 5.285
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.